{"transactions":[{"id":760343,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":43545,"kind":"person","name":"Ross Thomas W. Sr.","position":1,"cik":"0001669396","reported_name":"Ross Thomas W. Sr.","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2026-05-28T21:09:41.000Z","date":"2026-05-26","kind":"grant","planned":false,"acquired":true,"shares":15842,"price":15.78,"value":249986.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the annual grant of restricted share units (\"RSUs\") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders."}],"balance_after":85233,"source":{"system":"sec-edgar","filing":"0001860742-26-000081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000186074226000081/form4.xml","form_type":"4"}},{"id":861917,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":43545,"kind":"person","name":"Ross Thomas W. Sr.","position":1,"cik":"0001669396","reported_name":"Ross Thomas W. Sr.","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2026-03-04T21:18:54.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents matching restricted share units (\"MRSUs\") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances)."}],"balance_after":69391,"source":{"system":"sec-edgar","filing":"0001860742-26-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000186074226000053/form4.xml","form_type":"4"}},{"id":861916,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":43545,"kind":"person","name":"Ross Thomas W. Sr.","position":1,"cik":"0001669396","reported_name":"Ross Thomas W. Sr.","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2026-03-04T21:18:54.000Z","date":"2026-03-03","kind":"purchase","planned":false,"acquired":true,"shares":4500,"price":17.679,"value":79555.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.672 to $17.690 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":64891,"source":{"system":"sec-edgar","filing":"0001860742-26-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000186074226000053/form4.xml","form_type":"4"}},{"id":1132122,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":43545,"kind":"person","name":"Ross Thomas W. Sr.","position":1,"cik":"0001669396","reported_name":"Ross Thomas W. Sr.","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2025-05-28T20:10:50.000Z","date":"2025-05-27","kind":"grant","planned":false,"acquired":true,"shares":20338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the annual grant of restricted share units (\"RSUs\") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders."}],"balance_after":60391,"source":{"system":"sec-edgar","filing":"0001127602-25-015806","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760225015806/form4.xml","form_type":"4"}},{"id":1439693,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":43545,"kind":"person","name":"Ross Thomas W. Sr.","position":1,"cik":"0001669396","reported_name":"Ross Thomas W. Sr.","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2024-08-06T22:06:31.000Z","date":"2024-08-02","kind":"grant","planned":false,"acquired":true,"shares":14696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the annual grant of restricted stock units (\"RSUs\") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders."}],"balance_after":40053,"source":{"system":"sec-edgar","filing":"0001127602-24-021760","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760224021760/form4.xml","form_type":"4"}},{"id":1885837,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":43545,"kind":"person","name":"Ross Thomas W. Sr.","position":1,"cik":"0001669396","reported_name":"Ross Thomas W. Sr.","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2023-05-19T20:24:30.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":29205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":161516,"source":{"system":"sec-edgar","filing":"0001127602-23-016300","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760223016300/form4.xml","form_type":"4"}},{"id":1903032,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":43545,"kind":"person","name":"Ross Thomas W. Sr.","position":1,"cik":"0001669396","reported_name":"Ross Thomas W. Sr.","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2023-05-05T20:32:21.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":12857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the annual grant of restricted stock units (\"RSUs\") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders."}],"balance_after":25357,"source":{"system":"sec-edgar","filing":"0001127602-23-014713","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760223014713/form4.xml","form_type":"4"}},{"id":2220536,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":43545,"kind":"person","name":"Ross Thomas W. Sr.","position":1,"cik":"0001669396","reported_name":"Ross Thomas W. Sr.","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2022-06-28T20:45:58.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":34387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":132311,"source":{"system":"sec-edgar","filing":"0001127602-22-018206","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760222018206/form4.xml","form_type":"4"}},{"id":2273646,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":43545,"kind":"person","name":"Ross Thomas W. Sr.","position":1,"cik":"0001669396","reported_name":"Ross Thomas W. Sr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, No Par Value","published_at":"2022-05-12T23:37:55.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the \"Plan\"). Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation (the \"Company\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs are scheduled to vest on the date of the first regular annual meeting of the Company's shareholders in 2023, subject to the reporting person's continued service through such date."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0000899243-22-017855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000089924322017855/doc4.xml","form_type":"4"}},{"id":2733564,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":43545,"kind":"person","name":"Ross Thomas W. Sr.","position":1,"cik":"0001669396","reported_name":"Ross Thomas W. Sr.","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2021-05-03T20:14:42.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":7645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":97924,"source":{"system":"sec-edgar","filing":"0001127602-21-014916","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221014916/form4.xml","form_type":"4"}},{"id":3165815,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":43545,"kind":"person","name":"Ross Thomas W. Sr.","position":1,"cik":"0001669396","reported_name":"Ross Thomas W. Sr.","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2020-05-01T20:32:32.000Z","date":"2020-05-01","kind":"grant","acquired":true,"shares":11037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $200,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":90279,"source":{"system":"sec-edgar","filing":"0001127602-20-015042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220015042/form4.xml","form_type":"4"}},{"id":3209770,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":43545,"kind":"person","name":"Ross Thomas W. Sr.","position":1,"cik":"0001669396","reported_name":"Ross Thomas W. Sr.","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2020-03-16T20:24:51.000Z","date":"2020-03-12","kind":"purchase","acquired":true,"shares":2500,"price":15.535,"value":38837.5,"ownership":{"direct":true},"balance_after":79242,"source":{"system":"sec-edgar","filing":"0001127602-20-010794","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220010794/form4.xml","form_type":"4"}},{"id":3540914,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":43545,"kind":"person","name":"Ross Thomas W. Sr.","position":1,"cik":"0001669396","reported_name":"Ross Thomas W. Sr.","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2019-05-03T20:19:50.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":10633,"price":23.51,"value":249981.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of Bausch Health Companies Inc. (\"Bausch Health\") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health (the \"Annual Meeting\").  The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health."}],"balance_after":76802,"source":{"system":"sec-edgar","filing":"0001127602-19-017271","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219017271/form4.xml","form_type":"4"}},{"id":3943320,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":43545,"kind":"person","name":"Ross Thomas W. Sr.","position":1,"cik":"0001669396","reported_name":"Ross Thomas W. Sr.","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2018-05-08T20:42:20.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":13881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of Valeant Pharmaceuticals International, Inc. (\"Valeant\") on the third business day following their election at the Annual Meeting of Shareholders of Valeant (the \"Annual Meeting\").  The RSUs have a grant date value equal to $250,000, vest immediately prior to Valeant's next Annual Meeting, and are settled in common shares, no par value, of Valeant."},{"field":"shares","element":"transactionShares","label":"F2","text":"This Amended Form 4 is being filed to correct the number of RSUs acquired on May 3, 2018 as reported on the Form 4 filed on May 4, 2018."}],"balance_after":66169,"source":{"system":"sec-edgar","filing":"0001127602-18-016656","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218016656/form4a.xml","form_type":"4/A","original_submission_date":"2018-05-04"}},{"id":3946120,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":43545,"kind":"person","name":"Ross Thomas W. Sr.","position":1,"cik":"0001669396","reported_name":"Ross Thomas W. Sr.","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2018-05-04T22:02:14.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":14285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of Valeant Pharmaceuticals International, Inc. (\"Valeant\") on the third business day following their election at the Annual Meeting of Shareholders of Valeant (the \"Annual Meeting\").  The RSUs have a grant date value equal to $250,000, vest immediately prior to Valeant's next Annual Meeting, and are settled in common shares, no par value, of Valeant."}],"balance_after":66573,"source":{"system":"sec-edgar","filing":"0001127602-18-016413","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218016413/form4.xml","form_type":"4"}},{"id":4332298,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":43545,"kind":"person","name":"Ross Thomas W. Sr.","position":1,"cik":"0001669396","reported_name":"Ross Thomas W. Sr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2017-05-05T21:09:49.000Z","date":"2017-05-05","kind":"grant","acquired":true,"shares":25406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Regular annual Restricted Share Units (RSUs) equal to $250,000 granted to non-employee directors in office on the third trading day following the Annual Meeting of Shareholders based on the closing price of registrant common stock on the date prior to the grant.   RSUs represent a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc."}],"balance_after":52288,"source":{"system":"sec-edgar","filing":"0000885590-17-000026","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000088559017000026/primary_doc.xml","form_type":"4"}},{"id":4519689,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":43545,"kind":"person","name":"Ross Thomas W. Sr.","position":1,"cik":"0001669396","reported_name":"Ross Thomas W. Sr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2016-12-16T21:19:23.000Z","date":"2016-12-14","kind":"purchase","acquired":true,"shares":5000,"price":14.73,"value":73650.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of purchases of 5,000 shares of common stock (\"Shares\") of Valeant Pharmaceuticals International, Inc. (the \"Company\") at prices ranging from $14.72-$14.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of Shares purchased by the reporting person at each separate price within the range set forth in this footnote."}],"balance_after":26822,"source":{"system":"sec-edgar","filing":"0001669396-16-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000166939616000004/primary_doc.xml","form_type":"4"}}]}